|
Market Closed -
Nasdaq
16:00:00 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 67.29 USD | +2.58% |
|
+9.15% | +312.57% |
| 09-09 | UBS Adjusts Price Target on 10x Genomics to $68 From $20, Keeps Neutral Rating | MT |
| 09-09 | 10x Genomics Insider Sold Shares Worth $1,235,072, According to a Recent SEC Filing | MT |
| Market Cap | 8.77B 7.54B 7.1B 6.47B 12.11B 834B 12.16B 84.19B 32.54B 425B 32.92B 32.21B 1,346B | P/E 2026 * |
-93.7x | P/E 2027 * | -97.1x |
|---|---|---|---|---|---|
| Enterprise Value | 8.3B 7.14B 6.73B 6.13B 11.47B 790B 11.51B 79.73B 30.81B 402B 31.18B 30.5B 1,275B | EV / Sales 2026 * |
13.4x | EV / Sales 2027 * | 12.1x |
| Free-Float |
90.86% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TXG | Delayed | |
CBOE
| TXG | Real-time | |
|
Tradegate
| 1KJ | Real-time | |
|
Börse Stuttgart
| 1KJ | Delayed | |
|
London S.E.
| 0A88 | Delayed | |
|
Boerse Muenchen
| 1KJ | Real-time | |
|
Deutsche Boerse AG
| 1KJ | Delayed |
Last Transcript : 10x Genomics, Inc.
| 1 day | +2.58% | ||
| 1 week | +9.15% | ||
| Current month | +7.75% | ||
| 1 month | +29.33% | ||
| 3 months | +119.97% | ||
| 6 months | +221.81% | ||
| Current year | +312.57% |
| 1 week | 60.99 |  | 67.62 |
| 1 month | 55.25 | | 67.62 |
| Current year | 15.9 | | 67.62 |
| 1 year | 11.16 | | 67.62 |
| 3 years | 6.78 | | 67.62 |
| 5 years | 6.78 | | 187.85 |
| 10 years | 6.78 | | 208.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Serge Saxonov
CEO | Chief Executive Officer | 49 | 2012-07-01 |
Ben Hindson
PSD | President | 51 | 2012-09-30 |
Adam Taich
DFI | Director of Finance/CFO | 51 | 2024-08-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Ben Hindson
BRD | Director/Board Member | 51 | 2012-07-01 |
Serge Saxonov
BRD | Director/Board Member | 49 | 2012-07-01 |
John Stuelpnagel
CHM | Chairman | 68 | 2013-07-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/1/26 | Don | Founder | -100 | 0.0001% | ||
| 8/26/26 | Sell | Founder | -10,486 | 0.0090% | ||
| 8/24/26 | Sell | Chief Financial Officer | -17,166 | 0.0147% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.58% | +9.15% | +398.44% | +42.08% | 8.77B | |
| +1.12% | -0.17% | +173.86% | +382.74% | 21.84B | |
| -0.49% | -5.16% | -37.33% | -22.13% | 9.81B | |
| -3.18% | -3.10% | -29.22% | - | 6.79B | |
| +0.26% | -0.11% | +82.86% | +51.66% | 6.57B | |
| -1.42% | -2.98% | -29.46% | -20.49% | 5.75B | |
| +0.52% | -3.12% | -9.80% | -19.44% | 4.26B | |
| -2.77% | -4.25% | +63.66% | +79.79% | 4.08B | |
| -0.53% | -2.70% | -23.88% | -30.15% | 2.73B | |
| -1.17% | +1.78% | -21.71% | -2.38% | 1.37B | |
| Average | -0.51% | -0.85% | +56.74% | +51.30% | 7.2B | |
| Weighted average by Cap. | +0.03% | -0.55% | +100.38% | +136.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 620M 534M 502M 458M 856M 59B 860M 5.95B 2.3B 30.06B 2.33B 2.28B 95.22B | 680M 585M 551M 502M 939M 64.71B 943M 6.53B 2.52B 32.97B 2.55B 2.5B 104B |
| Net income | -94.29M -81.14M -76.4M -69.61M -130M -8.97B -131M -905M -350M -4.57B -354M -346M -14.48B | -88.67M -76.3M -71.84M -65.46M -122M -8.44B -123M -851M -329M -4.3B -333M -326M -13.62B |
| Net Debt | -465M -400M -377M -343M -642M -44.25B -645M -4.47B -1.73B -22.54B -1.75B -1.71B -71.41B | -521M -448M -422M -385M -720M -49.57B -722M -5B -1.93B -25.25B -1.96B -1.91B -80B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-09 | US$67.29 | +2.58% | 2,767,343 |
| 26-09-08 | US$65.60 | +4.71% | 3,382,284 |
| 26-09-04 | US$62.65 | -0.90% | 1,469,824 |
| 26-09-03 | US$63.22 | +2.55% | 2,172,711 |
| 26-09-02 | US$61.65 | +2.78% | 1,604,988 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TXG Stock
Select your edition
All financial news and data tailored to specific country editions
